Skip to content
Loading company
Loading

Latest annual · FY2025

Millions
Free cash flow
173

Latest quarter · Q3 FY2026

Millions
Total revenues
55
Gross profit
30
Operating income
(7)
Net income
(15)
Open Financials

CorMedix Inc. (CRMD) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$311.7 million$43.5 million+617%10-K 2026-03-05 · proof
Gross profit$275.7 million$40.3 million+584.6%10-K 2026-03-05 · proof
Operating income$150.1 million-$22.4 million10-K 2026-03-05 · proof
Net income$163.1 million-$17.9 million10-K 2026-03-05 · proof
Cash from operating activities$175 million-$50.6 million10-K 2026-03-05 · proof
Free cash flow$172.8 million-$50.7 million10-K 2026-03-05 · proof
Total assets$826.1 million$118.8 million+595.1%10-K 2026-03-05 · proof
Total liabilities$420.8 million$34.2 million+1,130.9%10-K 2026-03-05 · proof
Cash and cash equivalents$144.8 million$40.7 million+256.3%10-K 2026-03-05 · proof
What was CorMedix Inc. (CRMD)'s revenue in fiscal 2025?
CorMedix Inc. (CRMD) reported revenue of $311.7 million for fiscal 2025 (the year ended Dec 31, 2025), against $43.5 million the year before (+617%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What was CorMedix Inc. (CRMD)'s gross profit in fiscal 2025?
CorMedix Inc. (CRMD) reported gross profit of $275.7 million for fiscal 2025 (the year ended Dec 31, 2025), against $40.3 million the year before (+584.6%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What was CorMedix Inc. (CRMD)'s operating income in fiscal 2025?
CorMedix Inc. (CRMD) reported operating income of $150.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$22.4 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What was CorMedix Inc. (CRMD)'s net income in fiscal 2025?
CorMedix Inc. (CRMD) reported net income of $163.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$17.9 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What was CorMedix Inc. (CRMD)'s cash from operating activities in fiscal 2025?
CorMedix Inc. (CRMD) reported cash from operating activities of $175 million for fiscal 2025 (the year ended Dec 31, 2025), against -$50.6 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What was CorMedix Inc. (CRMD)'s free cash flow in fiscal 2025?
CorMedix Inc. (CRMD) reported free cash flow of $172.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$50.7 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What are CorMedix Inc. (CRMD)'s total assets?
As of Dec 31, 2025, CorMedix Inc. (CRMD) reported total assets of $826.1 million, against $118.8 million a year earlier (+595.1%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What are CorMedix Inc. (CRMD)'s total liabilities?
As of Dec 31, 2025, CorMedix Inc. (CRMD) reported total liabilities of $420.8 million, against $34.2 million a year earlier (+1,130.9%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
What are CorMedix Inc. (CRMD)'s cash and cash equivalents?
As of Dec 31, 2025, CorMedix Inc. (CRMD) reported cash and cash equivalents of $144.8 million, against $40.7 million a year earlier (+256.3%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CRMD&period_type=annual&limit=5"

Information only, not investment advice.